Recent Quotes (30 days)

You have no recent quotes
chg | %

Antares Pharma Inc  

(Public, NASDAQ:ATRS)   Watch this stock  
Find more results for ATRS
1.84
-0.05 (-2.65%)
Nov 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.83 - 1.90
52 week 1.58 - 4.09
Open 1.88
Vol / Avg. 684,777.00/3.06M
Mkt cap 287.79M
P/E     -
Div/yield     -
EPS -0.11
Shares 156.67M
Beta 0.24
Inst. own 35%
Nov 7, 2017
Q3 2017 Antares Pharma Inc Earnings Call - Webcast
Sep 26, 2017
Antares Pharma Inc at Ladenburg Thalmann Healthcare Conference
Sep 11, 2017
Antares Pharma Inc at Rodman & Renshaw Global Investment Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -36.22% -46.61%
Operating margin -32.86% -46.18%
EBITD margin - -42.62%
Return on average assets -27.03% -32.26%
Return on average equity -57.34% -43.36%
Employees 110 -
CDP Score - -

Address

SUITE 300, 100 PRINCETON SOUTH
EWING, NJ 8628
United States - Map
+1-609-3593020 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.

Officers and directors

Leonard S. Jacob M.D., Ph.D. Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Robert F. Apple CPA President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Fred M. Powell CPA Chief Financial Officer, Senior Vice President, Principal Financial Officer and Principal Accounting Officer
Age: 50
Bio & Compensation  - Reuters
Peter J. Graham Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer
Age: 48
Bio & Compensation  - Reuters
Thomas J. Garrity Independent Director
Age: 66
Bio & Compensation  - Reuters
Jacques Gonella Ph.D. Independent Director
Age: 73
Bio & Compensation  - Reuters
Anton G. Gueth Independent Director
Age: 58
Bio & Compensation  - Reuters
Robert P. Roche Jr. Independent Director
Age: 60
Bio & Compensation  - Reuters
Marvin S. Samson Independent Director
Age: 74
Bio & Compensation  - Reuters